About this service
A patient service hosted by the National LGBT Cancer Project, Malecare, and Cancer Academy.
Why it exists
LGBTQ people with cancer face two problems at once. The first is finding a trial that fits the medicine. The second is finding out, before making a phone call, whether a protocol and a research site will treat them with respect. Most trial finders answer only the first question. This service answers three questions, and keeps them apart.
- Does this trial appear medically relevant?
- What evidence shows whether the protocol includes LGBTQ patients?
- What evidence shows whether the specific research site provides respectful, affirming care?
What it does not do
- It does not diagnose anything.
- It does not recommend a treatment.
- It does not confirm that you are eligible for a trial.
- It does not choose a trial for you or enroll you in one.
Only the research team decides final eligibility. Everything here is education and navigation, built so you can have a better conversation with your oncologist and with a study coordinator.
Where the data comes from
Trial records come from ClinicalTrials.gov through its official API: recruitment status, locations, contacts, eligibility criteria, phase, sponsor, and record update dates. Each result shows when the record was last updated so you can judge how current it is.
Free-text eligibility criteria are read by structured, reviewable rules, and the original language is always kept and shown next to any plain-language explanation.
This release
The first release covers recruiting prostate cancer trials. The underlying platform is built as a shared clinical core plus a configuration-based cancer module, so other cancer types can be added without rebuilding matching, inclusion evidence, or site verification.